Clinical study design

Results: 811



#Item
281MediciNova to Initiate Clinical Trial of MN-166 (ibudilast) in ALS LA JOLLA, Calif., August 25, 2014 (GLOBE NEWSWIRE)-- MediciNova, Inc. a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and th

MediciNova to Initiate Clinical Trial of MN-166 (ibudilast) in ALS LA JOLLA, Calif., August 25, 2014 (GLOBE NEWSWIRE)-- MediciNova, Inc. a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and th

Add to Reading List

Source URL: www.alsconsortium.org

Language: English - Date: 2014-09-11 11:14:45
282Research / Evaluation methods / Design of experiments / Pharmacology / Market research / Institutional review board / Survey methodology / Clinical research coordinator / Clinical trial / Science / Clinical research / Statistics

By participating in this data collection activity, you are consenting to participate in a research study, the purpose of which is to determine the effectiveness of an educational program. The results of this research stu

Add to Reading List

Source URL: wvde.state.wv.us

Language: English - Date: 2013-04-25 09:01:59
283Case Studies Illustrating Revised NIH Clinical Trial Definition Case #1: A study will test de-identified, archived, human blood samples for which the researchers will not have access to identifying information. The sampl

Case Studies Illustrating Revised NIH Clinical Trial Definition Case #1: A study will test de-identified, archived, human blood samples for which the researchers will not have access to identifying information. The sampl

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2014-10-24 12:25:07
284PBTC[removed]A SUMMARY FOR PATIENTS AND FAMILIES Title: PBTC-042- A Phase 1 Study of CDK 4-6 inhibitor PD[removed]in children with recurrent, progressive, or refractory central nervous system tumors. This is a brief summar

PBTC[removed]A SUMMARY FOR PATIENTS AND FAMILIES Title: PBTC-042- A Phase 1 Study of CDK 4-6 inhibitor PD[removed]in children with recurrent, progressive, or refractory central nervous system tumors. This is a brief summar

Add to Reading List

Source URL: www.pbtc.org

Language: English - Date: 2014-09-05 17:20:54
285When to Stop a Clinical Trial Early for Benefit: Lessons Learned and Future Approaches Faiez Zannad, Wendy Gattis Stough, John J.V. McMurray, Willem J. Remme, Bertram Pitt, Jeffrey S. Borer, Nancy L. Geller and Stuart J.

When to Stop a Clinical Trial Early for Benefit: Lessons Learned and Future Approaches Faiez Zannad, Wendy Gattis Stough, John J.V. McMurray, Willem J. Remme, Bertram Pitt, Jeffrey S. Borer, Nancy L. Geller and Stuart J.

Add to Reading List

Source URL: www.globalcvctforum.com

Language: English - Date: 2014-10-08 08:34:48
286Research Ethics Board Guidelines for Completing the Research Study Application General These guidelines are available to assist in completing the application form. The answers to all questions must be detailed on this fo

Research Ethics Board Guidelines for Completing the Research Study Application General These guidelines are available to assist in completing the application form. The answers to all questions must be detailed on this fo

Add to Reading List

Source URL: en.horizonnb.ca

Language: English - Date: 2011-11-17 13:50:54
287Clinical research / Evaluation methods / Design of experiments / Pharmacology / Market research / Survey methodology / Institutional review board / Statistics / Science / Scientific method

By filling out this survey, you are agreeing to take part in a research study. The purpose of the study is to find out how well an education program is working. What we learn from this study may help improve this program

Add to Reading List

Source URL: wvde.state.wv.us

Language: English - Date: 2013-04-25 09:02:01
288Clinical research / Design of experiments / Pharmacology / Scientific method / Clinical trial / Point and click / Institutional review board / CTEP / Click consonant / Science / Evaluation methods / Information

Proposal No.: Study Title: Submitted By: Date Submitted:

Add to Reading List

Source URL: ctep.cancer.gov

Language: English - Date: 2014-10-19 20:09:41
289WHO Prequalification Team - Medicines  Guidance Document 28 July[removed]Additional guidance for submission of the Acceptability Study for

WHO Prequalification Team - Medicines Guidance Document 28 July[removed]Additional guidance for submission of the Acceptability Study for

Add to Reading List

Source URL: apps.who.int

Language: English - Date: 2014-07-29 07:30:34
290Lupron Depot® L-BT04-093 Abbreviated Clinical Study Report R&D[removed]Abbott Endocrine

Lupron Depot® L-BT04-093 Abbreviated Clinical Study Report R&D[removed]Abbott Endocrine

Add to Reading List

Source URL: www.abbvie.com

Language: English - Date: 2014-10-07 22:05:34